CIK 0000832489 · Non-accelerated filer<br>Smaller reporting company
GeoVax Labs, Inc.
Sign in to watch- Ticker
- GOVX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870455038
- Phone
- 678-384-7220
- Business address
- 1955 LAKE PARK DRIVE, SUITE 300, SMYRNA, GA
- Former names
- DAUPHIN TECHNOLOGY INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-22 | DODD DAVID A President, CEO | Purchase | +8,209 | $2.27 | $19K | 18,661 |
| 2024-02-21 | DODD DAVID A President, CEO | Purchase | +520 | $2.15 | $1K | 10,452 |
| 2024-02-07 | Reynolds Mark CFO | Purchase | +2,000 | $2.77 | $6K | 7,213 |
| 2023-12-22 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +6,944 | $0.36 | $2K | 35,782 |
| 2023-09-25 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +9,653 | $0.52 | $5K | 28,838 |
| 2023-08-25 | DODD DAVID A President, CEO | Purchase | +35,087 | $0.57 | $20K | 148,957 |
| 2023-08-18 | Reynolds Mark CFO | Purchase | +10,000 | $0.52 | $5K | 78,184 |
| 2023-08-01 | SPENCER JOHN N JR Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2023-08-01 | Morgan Jayne Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2023-08-01 | MCNALLY ROBERT T Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2023-08-01 | Lemerond Nicole Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2023-08-01 | Kollintzas Dean G Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2023-08-01 | CHASE RANDAL D Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2023-08-01 | McKee Kelly T. Jr. Chief Medical Officer | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2023-08-01 | Sharkey John W. VP, Business Development | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2023-08-01 | NEWMAN MARK J Chief Scientific Officer | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2023-08-01 | DODD DAVID A President, CEO | Grant or award · Stock Option | +250,000 | 250,000 | ||
| 2023-08-01 | Reynolds Mark CFO | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2023-04-24 | DODD DAVID A President, CEO | Purchase | +32,000 | $0.64 | $20K | 113,870 |
| 2023-04-20 | Reynolds Mark CFO | Purchase | +8,000 | $0.63 | $5K | 68,184 |
Page 3 of 6 · 107 trades